Vanquabio
Founded 2019 · 36 employees on LinkedIn · 3 known investors
Vanqua Bio is a biopharmaceutical company that discovers and develops medicines for neurodegenerative diseases, with a lead program targeting glucocerebrosidase (GCase) for Parkinson's disease and Dementia with Lewy Bodies, and additional programs addressing innate immune overactivation in disorders including Alzheimer's disease.
Founders & leadership
JS
Jim SullivanCEO
Investors · 3
Frequently asked questions
- What does Vanquabio do?
- Vanqua Bio is a biopharmaceutical company that discovers and develops medicines for neurodegenerative diseases, with a lead program targeting glucocerebrosidase (GCase) for Parkinson's disease and Dementia with Lewy Bodies, and additional programs addressing innate immune overactivation in disorders including Alzheimer's disease.
- Who are Vanquabio's investors?
- Vanquabio's investors include Avoro Capital Advisors, OrbiMed, Pontifax Venture Capital.